ARTICLE: G. Grisay, F. Turco, A. Patrikidou, E. Gallardo Díaz, R. S. McDermott, S. Litiere, B. Fournier, S. Gillessen, B. F. Tombal (2024) EORTC GUCG 2238 De-escalate: A pragmatic trial to revisit intermittent androgen-deprivation therapy in metastatic hormone-naïve prostate cancer in the era of new AR pathway inhibitors. DOWNLOAD
To Be Updated Soon
© The DE-ESCALATE Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101104574 ).
Copyright © 2024 All rights reserved.